electroCore (NASDAQ:ECOR) Trading 7.5% Higher

electroCore, Inc. (NASDAQ:ECOR)’s share price traded up 7.5% during trading on Wednesday . The stock traded as high as $2.06 and last traded at $2.00, 219,004 shares changed hands during mid-day trading. An increase of 13% from the average session volume of 193,545 shares. The stock had previously closed at $1.86.

Several equities research analysts have commented on the company. Evercore ISI restated a “buy” rating and issued a $24.00 price objective on shares of electroCore in a research report on Tuesday, August 13th. BTIG Research reiterated a “hold” rating on shares of electroCore in a research report on Wednesday, August 14th. Noble Financial reiterated a “buy” rating and set a $11.00 target price on shares of electroCore in a research report on Thursday, August 15th. ValuEngine upgraded electroCore from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Finally, JMP Securities decreased their target price on electroCore to $10.00 and set a “positive” rating on the stock in a research report on Thursday, August 15th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $11.15.

The stock has a market cap of $55.04 million, a PE ratio of -2.12 and a beta of 2.51. The company has a current ratio of 6.63, a quick ratio of 5.93 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average price of $2.58 and a 200-day moving average price of $3.43.

electroCore (NASDAQ:ECOR) last announced its earnings results on Tuesday, August 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.45) by $0.04. The business had revenue of $0.62 million for the quarter. Equities analysts expect that electroCore, Inc. will post -1.3 earnings per share for the current year.

In other electroCore news, Director Thomas J. Errico bought 18,974 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were purchased at an average price of $1.62 per share, for a total transaction of $30,737.88. The transaction was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 43.78% of the company’s stock.

Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of electroCore by 4.8% during the 2nd quarter. Vanguard Group Inc. now owns 664,936 shares of the company’s stock valued at $1,330,000 after buying an additional 30,671 shares in the last quarter. BlackRock Inc. lifted its holdings in electroCore by 3.7% in the 2nd quarter. BlackRock Inc. now owns 575,248 shares of the company’s stock valued at $1,150,000 after purchasing an additional 20,536 shares in the last quarter. Parametric Portfolio Associates LLC purchased a new position in electroCore in the 2nd quarter valued at $99,000. Bronfman E.L. Rothschild L.P. purchased a new position in electroCore in the 2nd quarter valued at $50,000. Finally, Rockefeller Capital Management L.P. purchased a new position in electroCore in the 2nd quarter valued at $28,000. Hedge funds and other institutional investors own 10.36% of the company’s stock.

About electroCore (NASDAQ:ECOR)

electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.

Recommended Story: What is a good rate of return for a mutual fund?

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.